bf/NYSE:CTLT_icon.png

NYSE:CTLT

Catalent

  • Stock

USD

Last Close

63.48

17/12 21:00

Market Cap

10.39B

Beta: 1.17

Volume Today

13.67M

Avg: 2.94M

PE Ratio

−11.39

PFCF: −45.82

    Description

    Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulat...Show More

    Earnings

    Earnings per Share (Estimate*)

    0.512017-08-282019-08-272021-08-302023-08-292024-11-05

    Revenue (Estimate*)

    1B2B3B4B2017-08-282019-08-272021-08-302023-08-292024-11-05

    *Estimate based on analyst consensus